Beckton Dickinson

US-based medical technology company Beckton Dickinson (BD; NYSE: BDX) has reported its financial results for the first quarter of the fiscal year 2024, ending December 31, 2023. In constant currency terms, sales increased by 1.6% year-on-year (YOY) to USD 4.7 billion. Breaking down the figures by business segment, BD Medical,…